Cargando…
Checkpoint blocker induced autoimmunity as an indicator for tumour efficacy in melanoma
Immune checkpoint inhibitors (ICI) have improved survival of patients with metastatic melanoma but can induce autoimmunologic side effects. Ye et al. report a retrospective analysis that further supports the finding that these are biomarkers for patients’ clinical benefit. Thereby, patients with imm...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770793/ https://www.ncbi.nlm.nih.gov/pubmed/34697417 http://dx.doi.org/10.1038/s41416-021-01390-1 |